Clinical Trial Update: A Study of Pediatric Patients With Attention Deficit/Hyperactivity Disorder [Phase 2, Phase 3]

View source ↗

Summary

A Phase 2/3 pediatric ADHD trial conducted by Eli Lilly has completed and posted results (results posted 2014-08-18).

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Attention Deficit Hyperactivity Disorder

Snippet

Sponsor: Eli Lilly and Company | Conditions: Attention Deficit Hyperactivity Disorder | Phase 2, Phase 3 | Status: COMPLETED | Results posted: 2014-08-18